John Matthew Maris, M.D.
Professor of Pediatrics
Department: Pediatrics
Graduate Group Affiliations
Contact information
The Children's Hospital of Philadelphia
Division of Oncology
Colket Translational Research Building
3501 Civic Center Boulevard #3060
4399
Philadelphia, PA 19104-4318
Division of Oncology
Colket Translational Research Building
3501 Civic Center Boulevard #3060
4399
Philadelphia, PA 19104-4318
Office: 215 590 5244
Fax: 267 426 0685
Fax: 267 426 0685
Email:
MARIS@EMAIL.CHOP.EDU
MARIS@EMAIL.CHOP.EDU
Publications
Links
Search PubMed for articles
CCCR Faculty Profile
Abramson Family Cancer Research Institute webpage.
Maris Lab Website
Search PubMed for articles
CCCR Faculty Profile
Abramson Family Cancer Research Institute webpage.
Maris Lab Website
Education:
B.S. (Biology)
Wheeling College , 1983.
M.D. (Medicine)
University of Pennsylvania, 1989.
Permanent linkB.S. (Biology)
Wheeling College , 1983.
M.D. (Medicine)
University of Pennsylvania, 1989.
Selected Publications
Suganuma Rie, Wang Larry L, Sano Hideki, Naranjo Arlene, London Wendy B, Seeger Robert C, Hogarty Michael D, Gastier-Foster Julie M, Look A Thomas, Park Julie R, Maris John M, Cohn Susan L, Amann Gabriele, Beiske Klaus, Cullinane Catherine J, d'Amore Emanuele S G, Gambini Claudio, Jarzembowski Jason A, Joshi Vijay V, Navarro Samuel, Peuchmaur Michel, Shimada Hiroyuki: Peripheral neuroblastic tumors with genotype-phenotype discordance: A report from the Children's Oncology Group and the International Neuroblastoma Pathology Committee. Pediatric blood & cancer 60(3): 363-70, Mar 2013.Mayes Patrick A, Degenhardt Yan Y, Wood Andrew, Toporovskya Yana, Diskin Sharon J, Haglund Elizabeth, Moy Christopher, Wooster Richard, Maris John M: Mitogen-activated protein kinase (MEK/ERK) inhibition sensitizes cancer cells to centromere-associated protein E inhibition. International journal of cancer. Journal international du cancer 132(3): E149-57, Feb 2013.
Seif A E, Naranjo A, Baker D L, Bunin N J, Kletzel M, Kretschmar C S, Maris J M, McGrady P W, von Allmen D, Cohn S L, London W B, Park J R, Diller L R, Grupp S A: A pilot study of tandem high-dose chemotherapy with stem cell rescue as consolidation for high-risk neuroblastoma: Children's Oncology Group study ANBL00P1. Bone marrow transplantation Jan 2013.
Lock Richard B, Carol Hernan, Maris John M, Kang Min H, Reynolds C Patrick, Kolb E Anders, Gorlick Richard, Keir Stephen T, Billups Catherine A, Kurmasheva Raushan T, Houghton Peter J, Smith Malcolm A: Initial testing (stage 1) of ganetespib, an Hsp90 inhibitor, by the pediatric preclinical testing program. Pediatric blood & cancer Jan 2013.
Capasso Mario, Diskin Sharon J, Totaro Francesca, Longo Luca, Mariano Marilena De, Russo Roberta, Cimmino Flora, Hakonarson Hakon, Tonini Gian Paolo, Devoto Marcella, Maris John M, Iolascon Achille: Replication of GWAS-identified neuroblastoma risk loci strengthens the role of BARD1 and affirms the cumulative effect of genetic variations on disease susceptibility. Carcinogenesis Jan 2013.
Russell Mike R, Levin Kirill, Rader Julieann, Belcastro Lili, Li Yimei, Martinez Daniel, Pawel Bruce, Shumway Stuart D, Maris John M, Cole Kristina A: Combination therapy targeting the chk1 and wee1 kinases shows therapeutic efficacy in neuroblastoma. Cancer research 73(2): 776-84, Jan 2013.
Keir Stephen T, Maris John M, Reynolds C Patrick, Kang Min H, Kolb E Anders, Gorlick Richard, Lock Richard, Carol Hernan, Morton Christopher L, Wu Jianrong, Kurmasheva Raushan T, Houghton Peter J, Smith Malcolm A: Initial testing (stage 1) of temozolomide by the pediatric preclinical testing program. Pediatric blood & cancer Jan 2013.
Pugh Trevor J, Morozova Olena, Attiyeh Edward F, Asgharzadeh Shahab, Wei Jun S, Auclair Daniel, Carter Scott L, Cibulskis Kristian, Hanna Megan, Kiezun Adam, Kim Jaegil, Lawrence Michael S, Lichenstein Lee, McKenna Aaron, Pedamallu Chandra Sekhar, Ramos Alex H, Shefler Erica, Sivachenko Andrey, Sougnez Carrie, Stewart Chip, Ally Adrian, Birol Inanc, Chiu Readman, Corbett Richard D, Hirst Martin, Jackman Shaun D, Kamoh Baljit, Khodabakshi Alireza Hadj, Krzywinski Martin, Lo Allan, Moore Richard A, Mungall Karen L, Qian Jenny, Tam Angela, Thiessen Nina, Zhao Yongjun, Cole Kristina A, Diamond Maura, Diskin Sharon J, Mosse Yael P, Wood Andrew C, Ji Lingyun, Sposto Richard, Badgett Thomas, London Wendy B, Moyer Yvonne, Gastier-Foster Julie M, Smith Malcolm A, Auvil Jaime M Guidry, Gerhard Daniela S, Hogarty Michael D, Jones Steven J M, Lander Eric S, Gabriel Stacey B, Getz Gad, Seeger Robert C, Khan Javed, Marra Marco A, Meyerson Matthew, Maris John M: The genetic landscape of high-risk neuroblastoma. Nature genetics Jan 2013.
Gorlick Richard, Kolb E Anders, Houghton Peter J, Morton Christopher L, Neale Geoffrey, Keir Stephen T, Carol Hernan, Lock Richard, Phelps Doris, Kang Min H, Reynolds C Patrick, Maris John M, Billups Catherine, Smith Malcolm A: Initial testing (stage 1) of the cyclin dependent kinase inhibitor SCH 727965 (dinaciclib) by the pediatric preclinical testing program. Pediatric blood & cancer 59(7): 1266-74, Dec 2012.
Gamazon Eric R, Pinto Navin, Konkashbaev Anuar, Im Hae Kyung, Diskin Sharon J, London Wendy B, Maris John M, Dolan M Eileen, Cox Nancy J, Cohn Susan L: Trans-population Analysis of Genetic Mechanisms of Ethnic Disparities in Neuroblastoma Survival. Journal of the National Cancer Institute Dec 2012.